About this episode
Alzheimer's Disease and Related Dementias are a terrible disease on individuals, caregivers, and communities. There are no cures. However, new data has come out discussing the risk factors, polypharmacy, and a potential early detection opportunity. It's time to de-prescribe and follow the money. Reference: Nicholas LH, Langa KM, Bynum JPW, Hsu JW. Financial Presentation of Alzheimer Disease and Related Dementias. JAMA Intern Med. 2021;181(2):220–227. doi:10.1001/jamainternmed.2020.6432 Maust DT, Strominger J, Kim HM, et al. Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US. JAMA. 2021;325(10):952–961. doi:10.1001/jama.2021.1195 CPE details for GameChangers Podcast April 2021 Learning Objective: Discuss if adverse financial outcomes may be a risk factor for future dementia diagnosis. 0107-0000-21-158-H01-P 0.2 CEU/2 Hrs (Knowledge) Initial Release Date: 04/06/21 Expiration Date: 03/02/24 Additional CPE information is located at https://www.ceimpact.com/podcast Disclosure: Dr. Galdo is a member of the Board of Directors for the Alabama Chapter of the Alzheimer's Association. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices